The T allele of TCF7L2 rs12255372 G/T Variant Can Predispose to Type 2 Diabetes Mellitus among Iraqi Population
doi.org/10.26538/tjnpr/v4i9.7
Keywords:
insulin resistance, rs12255372 variant, TCF7L2 gene, Diabetes mellitusAbstract
Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder, resulting from the interaction of genetic and environmental factors. This study aimed to assess the association of TCF7L2 rs12255372 G/T variant with T2DM and insulin resistance (IR) in a sample of the Iraqi population. A total of 76 patients with T2DM and 54 healthy controls were genotyped for the TCF7L2 rs7903146 single nucleotide polymorphism (SNP). The association of different genotypes of this SNP with the development of T2DM as well and with IR and glycated hemoglobin (HbA1c) were assessed. The TT genotype showed a higher frequency in diabetic patients (17.11%) than controls (5.56%) with a significant difference (OR = 4.04, 95% CI = 1.04-15.71, p = 0.044). Furthermore, the T allele was more frequent in patients than controls (38.82% vs. 26.85%), with a significant difference (OR = 1.73, 95% CI = 1.01-2.95, p = 0.45). Mean HOMA-IR in patients carrying TT genotype was 2.91 ± 0.83 which was significantly higher than either GG or GT genotype (2.62 ± 0.63 and 2.71 ± 0.55, respectively). Thus, the T allele of TCF7L2 rs12255372 variant could be considered as a risk factor for developing T2DM. The study suggests that increase IR is the underlying mechanism by which this variant can predispose the individual for T2DM.
References
Akram TK and Hisham MD. Diabetes mellitus: The epidemic of the century; World J Diabet 2015; 6(6):850- 867.
Yan Z, Sylvia HL, Frank HB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14:88-98.
Shiferaw BA and Ayalew JZ. Prevalence of diabetes mellitus and its risk factors among individuals aged 15 years and above in Mizan-Aman town, Southwest Ethiopia, 2016: a cross sectional study. Int J Endocrinol. 2018; ID 9317987.
Abbas AM and Fadhil A. Diabetes in Iraq: facing the epidemic. a systematic review. Wulfenia J 2015; 22(3):258- 273.
Zhou Y, Park SY, Su J, Bailey K, Ottosson-Laakso E, Scherbina L, Oskolkov N, Zhang E, Thevenin J, Bennet H, Vikman P, Wierup N, Fex M, Rung J, Wolheim C, Nobrega M, Renstorm E, Groop L, Hasson J. TCF7L2 is a master regulator of insulin production and processing. Hun Mol
Genet. 2014; 23(24):6419-6431.
Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by β-catenin andglycogen synthase kinase-3β. J Biol Chem 2005; 280:1457-1464.
Jin T and Liu L. Minireview: the Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol. 2008; 22(11):2383-2392.
Schafer SA, Tschritter O, Machico F, Thamer C, Stafan N, Gallwitz B, Holst JJ, Dekker JM, Hart LM, Nijpels G, van Haeften TW, Haring HU, Fitsche A. Impaired glucagon-like peptite-1-induced insulin secretion in carriers of transcription factor -7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 2007; 50:2443-2450.
Redondo MJ, Steck AK, Sosenko J, Anderson M, Antinozzi P, Michels A, Wentworth MA, Pugliese A, Geyer S. Transcription factor 7-like 2 (TCF7L2) gene polymorphism and progression from single to multiple autoantibody positivity in individuals at risk for type 1 diabetes. Diabet
Care 2018; 41(12):2480‐2486.
Bodhini D, Chidambaram M, Liju S, Prakash VG, Gayathri V, Shanthirani CS, Ranjith U, Anjana RM, Nohan V, Radha V. Association of TCF7L2 polymorphism with diabetic nephropathy in the Southern Indian Population. Ann Hum Gene. 2015; 79(5):373-379.
Alnaggar AR, El-salam RF, Rady NH, Ishak MF, Ammar SH. Study of the association of transcription factor 7like 2 gene polymorphism with typw 2 diabete mellitus and diabetic nephropathy in the Rgyptian population. Endoc Abstract 2018; 56:335.
Saadi H, Nagelkerke N, Carruthers SG, Benedict S, Abdulkhalek S, Reed R, Lukic M, Nicholls MG. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects. Daibet Res Clin Prac. 2008; 80:391- 398.
Nanfa D, Sobngwi E, Atogho-Tiedeu B, Noubiap JJN, Donfack OS,Mato Mofo EP, Guewo-Fokeng M, Metsadjio AN, Ngwa EN, Fosso PP, Djahmeni E, Djokam-Dadjeu ,Evehe M, Aminkeng F, Mbacham WF, Mbanya JC . Association between the TCF7L2 rs12255372 (G/T) gene
polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study. Clin Transl Med. 2015; 4:17.
Nanfa D, Sobngwi E, Atogho-Tiedeu B, Noubiap JJ, Donfack OS, Mofo EP, Guewo-Fokeng M, Nguimmo Metsadjio A, Ndonwi Ngwa E, Pokam Fosso P, Djahmeni, E, Djokam-Dadjeu R, Evehe MS, Aminkeng F, Mbacham WF. Mbanya JC. Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study. Clin Transl Med. 2015; 4:17.
American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabet Care 2013; 35(Suppl. 1):S64-S71.
Wang J, Zhang J, Li L, Wang Y, Wang Q, Zhai Y, You H, Hu D. Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis. Braz J Med Biol Res. 2013; 46(4):382–393.
Li Y, Yang X, Geng H, Gong G. Type 2 diabetes mellitus and TCF7L2 gene rs12255372 G/T polymorphism: a metaanalysis involving 7990 subjects. Int J Diabtes Dev Ctries 2018; 38:55-61
Chang YC, Chang TJ, Jiang YD, Kuo SS, Lee KC, Chiu KC, Chuang L. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabet. 2007; 56:2631-2637.
Guo T, Hanson RL, Traurig M, Muller YL, Ma L, Mack J, Kobes S, Knowler WC, Bogardus C, Baier LJ. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: Analysis of 3,501 individuals. Diabet. 2007; 56:3082-3088.
Alsmadi O, Al-Rubeaan K, Mohamed G, Alkayal F, AlSaud H, Al-Saud NA, Al-daghri N, Mohammed S, Meyer BF. Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population. BMC Med Genet. 2008; 9:e72.
Shokohi S, Delpisheh A, Haghani K, Mahdizadeh M, Bakhtiyari S. Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF2L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group. Clin Lab 2014; 60(8):1269-1276.
Velayutham K, Ramanathan B, Murugan J, Murugan A, Thavamani V, Gomathinayagam R. Carriers of the TCF7L2 rs7903146, rs12255372 Risk Alleles in the South Tamil Nadu T2DM Patients Present with Early Incidence and Insulin Dependence. Ind J Endocrinol Metab. 2019;
(5):563–569.
Pouahmadi M, Erfanian S, Moradzadeh M, Jahromi AS. Non-association between rs7903146 and rs12255372 polymorphisms in transcription factor-7-like 2 gene and type 2 diabetes mellitus in Jahrom city, Iran. Diabet Metab J. 2015; 39:512-517.
Mondal AK, Das SG, Chu WS, Sharma NK, Hackney OG, Zhao J, Grant SF, Elbein SC. Genotype and tissue specific effects on alternative splicing of the transcription factor 7- like 2 gene in humans. J Clin Endocrinol Metab. 2010; 95(95):1450–1457.
Shao W, Wang D, Chiang Y, Ip W, Zhu L, Xu F, Columbus J, Belsham DD, Irwin DM, Zhang H, Wen X, Wang Q, Jin T. The Wnt signaling pathway effector TCF7L2 controls gut and brain proglucagon gene expression and glucose homeostasis. Diabet. 2013; 62(3):789–800.
Nadkarni P, Chepurny OG, Holz GG. Regulation of glucose homeostasis by GLP-1. Prog Mol Biol Transl Sci. 2014; 121:23–65.
Manandhar B and Ahn J-M. Glucagon-like Peptide-1 (GLP- 1) analogs: recent advances, new possibilities, and therapeutic implications. J Med Chem. 2015; 58(3):1020–1037.
Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, Balkau B, Charpentier G, Pattou F, Stetsyuk V, Raphael S, Staels B, Fruhbeck G, Froguel P. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong
association with type 2 diabetes. Diabet. 2006; 55:2903–2908.
Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjögren M, Florez JC, Almgren P, Isomaa B, OrhoMelander M, Lindblad U, Daly MJ, Tuomi T, Hirschhorn JN, Ardlie KG, Groop LC, Altshuler D. Common singlenucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabet. 2006; 55:2890–2895.
Shah M, Varghese RT, Miles JM, Piccinini F, Dalla Man C, Cobelli C, Bailey KR, Rizza RA, Vella A. TCF7L2 Genotype and alpha-cell function in humans without diabetes. Diabet. 2016; 65:371–380.
Xia QH, Chesi A, Manduchi E, Johnston BT, Lu S, Leonard ME, Parlin UW, Rappaport EF, Huang P, Wells AD, Blobel GA, Johnson ME, Grant SF. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5. Diabetologia. 2016;
(11):2360–2368.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
